ML
Insider
Michael J. LaBarre
SVP, CHIEF TECHNICAL OFFICERMichael J. LaBarre (SVP, CHIEF TECHNICAL OFFICER) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in Halozyme Therapeutics, Inc. (HALO). The largest single filing was $1.1M of HALO (18,700 sh across 2 lots, as filed), executed Feb 25 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.2M
shares × price, as filed
Last traded
Feb 26 2025
Filed Feb 27 2025
Median ADV $214.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 24 months
Most traded names
HALORecent filings
HALOSALE
Halozyme Therapeutics, Inc.
View filing →
$1.1M18,700 sh across 2 lots
Exec Feb 25 2025
Filed Feb 27 2025 · 5:30 PM ET HALOSALE Halozyme Therapeutics, Inc. View filing → $1.1M
19,923 sh across 2 lots
Exec Oct 15 2024
Filed Oct 16 2024 · 5:30 PM ET HALOSALE Halozyme Therapeutics, Inc. View filing → $1.2M
20,000 sh across 3 lots
Exec Sep 17 2024
Filed Sep 18 2024 · 5:30 PM ET